Matthew Mei

31PUBLICATIONS
104CO-AUTHORS
HaematologyCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursImmunogenetics (incl. genetic immunology)Transplantation immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (31)

|Aug 12, 2026
Allogeneic heamatopoietic stem cell transplant in patients with refractory T-cell large granular lymphocytic leukaemia: A single-centre experience.

|Jun 25, 2026
Outcomes of patients with relapsed or refractory classic Hodgkin lymphoma after frontline brentuximab vedotin.

|Mar 18, 2026
Polatuzumab Vedotin Combined With R-ICE (PolaR-ICE) as Second-Line Therapy in Diffuse Large B-Cell Lymphoma.

Geoffrey Shouse, Matthew Matasar, Lu Chen

|Dec 17, 2025
PD-1-based combinations before autologous transplant are associated with improved outcomes in classical Hodgkin lymphoma.

Sanjal H Desai, Alison J Moskowitz, Reid W Merryman

|Nov 19, 2025
Mosunetuzumab is effective and well tolerated in older patients with relapsed/refractory follicular lymphoma: Subgroup analysis of a phase I/II study.

Swetha Kambhampati Thiruvengadam, Leslie L Popplewell, Alex F Herrera

|Oct 27, 2025
Cell-of-Origin Subtype Predicts Response to Polatuzumab Vedotin in Large B-cell Lymphoma.

Edward R Scheffer Cliff, Guido D Pelaez, Fei Wan

Pageof 6

Frequent Collaborators

8 joint publications

Alex F Herrera

6 joint publications

Tamer Othman

6 joint publications

Ibrahim Aldoss

5 joint publications

Lihua E Budde